Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-698-5 | CAS number: 3195-78-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.7 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 50
- Dose descriptor starting point:
- NOAEC
- Value:
- 50 mg/m³
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 35.175 mg/m³
- Explanation for the modification of the dose descriptor starting point:
No route to route extrapolation was used as one repeated inhalation exposure study was available. For details on calculations please refer to discussion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 4
- Justification:
- As the NOAEL of a repeated dose toxicity study (OECD 422) with an exposure time of 30 days (males) and 56 days (females) was used as point of departure an AF of 4 is considered as adequate for the exposure duration extrapolation.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.028 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 12.5
- Dose descriptor:
- NOAEC
- Value:
- 0.5 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation is conducted for local DNEL derivation.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.2 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEC
- Value:
- 50 mg/m³
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 39.9 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on repeated exposure by dermal route. For details on calculations please refer to discussion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 4
- Justification:
- As the NOAEL of a repeated dose toxicity study (OECD 422) with an exposure time of 30 days (males) and 56 days (females) was used as point of departure an AF of 4 is considered as adequate for the exposure duration extrapolation.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- acute toxicity
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
WORKER
General
DNEL derivation for the test substance is performed under consideration of the recommendations of ECHA. In view of the data used for evaluation, the "quality of whole database factors" and "dose-response factors" are considered to amount each to a value of 1, and are thus not shown in the calculations presented below.
Workers – Hazard via inhalation route
Long term systemic inhalation DNEL, worker
The DNEL long term, systemic (inhalation) is derived from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC (systemic) is 50 mg/m^3.
Step 2: Modification of the starting point:
No modification for absorption is used as the same exposure route is considered. Following corrections were performed:
Relevant dose descriptor (NOAEC): 50 mg/m^3
Standard respiratory volume of humans (sRVhuman) for 8 hours: 6.7 m³
Worker respiratory volume (wRV) for 8 hours with light physical activity: 10 m³
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of worker exposure: 5 days/week, 8 hours/day
Corrected inhalatory NOAEC for workers
= 50 mg/m^3 * (6.7 m³/10 m³) * (7/5) * (6/8)
= 35.175 mg/m³
Step 3: Use of assessment factors: 50
Interspecies AF, allometric scaling (rat to human): 1
Interspecies AF, remaining differences: 2.5
Intraspecies AF (worker): 5
Exposure duration AF: 4
Remaining uncertainties AF: 1
In conclusion, long term systemic inhalation DNEL, worker = 0.7035 mg/m^3
Short term systemic inhalation DNEL, worker
The test material is not classified and labelled for acute systemic toxicity (inhalation), according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required.
Long term local inhalation DNEL, worker
The DNEL long term, local (inhalation) is derived from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC (local) is 0.5 mg/m^3.
Step 2: Modification of the starting point:
No modification for absorption is used as the same exposure route is considered. Following corrections were performed:
Relevant dose descriptor (NOAEC): 0.5 mg/m^3
Standard respiratory volume of humans (sRVhuman) for 8 hours: 6.7 m³
Worker respiratory volume (wRV) for 8 hours with light physical activity: 10 m³
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of worker exposure: 5 days/week, 8 hours/day
Corrected inhalatory NOAEC for workers
= 0.5 mg/m^3 * (6.7 m³/10 m³) * (7/5) * (6/8)
= 0.35175 mg/m³
Step 3: Use of assessment factors: 12.5
Interspecies AF, allometric scaling (rat to human): 1
Interspecies AF, remaining differences: 2.5
Intraspecies AF (worker): 5
Exposure duration AF: 1 (No time extrapolation is conducted for local DNEL derivation.)
Remaining uncertainties AF: 1
In conclusion, long term local inhalation DNEL, worker = 0.02814 mg/m^3
Short term local inhalation DNEL, worker
Short term local inhalation effects are covered by the long term local risk assessment and no quantitative acute local inhalation assessment is required (in accordance with "Guidance on information requirements and chemical safety assessment", Part E).
Workers – Hazard via dermal route
Long term systemic dermal DNEL, worker
The DNEL long term, systemic (dermal) is derived by route-to route extrapolation from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC is 50 mg/m^3.
Step 2: Modification of the starting point:
Due to the physic-chemical properties the dermal uptake is considered to be 50 % of the inhalation uptake in the worst case.
Factor for dermal NOAEL= 100 % inhalation / 50 % dermal= 2
Standard respiratory volume of the rat (sRVrat) for 8 hours: 0.38 m³/kg bw/d
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of worker exposure: 5 days/week, 8 hours/day
inhalation NOAEC 50 mg/m^3 * 2 * 0.38 m³/kg bw/d * (7/5) * (6/8)= 39.9 mg/kg bw/day dermal NOAEL
Step 3: Use of assessment factors: 200
Interspecies AF, allometric scaling (rat to human): 4
Interspecies AF, remaining differences: 2.5
Intraspecies AF (worker): 5
Exposure duration AF: 4
Remaining uncertainties AF: 1
In conclusion, long term systemic dermal DNEL, workers = 0.1995 mg/kg bw/day.
Long term local dermal DNEL, worker
The test material is not classified and labelled for skin sensitization or skin irritation, according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required.
Short term local dermal DNEL, worker
The test material is not classified and labelled for skin sensitization or skin irritation, according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required.
Worker – Hazard for the eyes
For exposure to the eyes a low hazard was identified, as the test substance is classified for eye irritation Cat.2 according to Regulation (EC) No 1272/2008 (CLP). A qualitative risk assessment is conducted (in accordance with "Guidance on information requirements and chemical safety assessment", Part E).
References
(not included as endpoint study record)
- ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2.1. November 2012.
- ECHA (2014). Guidance on information requirements and chemical safety assessment.Chapter R.7.12: Endpoint specific guidance: Guidance on Toxicokinetics. November 2014.
- ECHA (2012) Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report, November 2012.
- ECHA (2016). Guidance on information requirements and chemical safety assessment.Part E: Risk Characterisation, Version 3.0, May 2016.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.125 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEC
- Value:
- 50 mg/m³
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 12.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
No route to route extrapolation was used as one repeated inhalation exposure study was available. For details on calculations please refer to discussion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 4
- Justification:
- As the NOAEL of a repeated dose toxicity study (OECD 422) with an exposure time of 30 days (males) and 56 days (females) was used as point of departure an AF of 4 is considered as adequate for the exposure duration extrapolation.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.005 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 25
- Dose descriptor:
- NOAEC
- Value:
- 0.5 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation is conducted for local DNEL derivation.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scalling is applied for inhalation as the inhalative data is standardized with reference to the respiratory rates. Respiratory rates depend directly on caloric demand, therefore inhalative study results are already extrapolated to humans on the basis of metabolic rate scaling (=allometric scaling).
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.072 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 400
- Dose descriptor starting point:
- NOAEC
- Value:
- 50 mg/m³
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 28.75 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on repeated exposure by dermal route. For details on calculations please refer to discussion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 4
- Justification:
- As the NOAEL of a repeated dose toxicity study (OECD 422) with an exposure time of 30 days (males) and 56 days (females) was used as point of departure an AF of 4 is considered as adequate for the exposure duration extrapolation.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.216 mg/kg bw/day
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Dermal
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.036 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 400
- Dose descriptor starting point:
- NOAEC
- Value:
- 50
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 14.375 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on repeated exposure by oral route. For details on calculations please refer to discussion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 4
- Justification:
- As the NOAEL of a repeated dose toxicity study (OECD 422) with an exposure time of 30 days (males) and 56 days (females) was used as point of departure an AF of 4 is considered as adequate for the exposure duration extrapolation.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- The default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Recommended AF for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.108 mg/kg bw/day
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 3
- DNEL extrapolated from long term DNEL
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
General Population
General
DNEL derivation for the test substance is performed under consideration of the recommendations of ECHA. In view of the data used for evaluation, the "quality of whole database factors" and "dose-response factors" are considered to amount each to a value of 1, and are thus not shown in the calculations presented below.
General population – Hazard via inhalation route
Long term systemic inhalation DNEL, General population
The DNEL long term, systemic (inhalation) is derived from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC (systemic) is 50 mg/m^3.
Step 2: Modification of the starting point:
No modification for absorption is used as the same exposure route is considered. Following corrections were performed:
Relevant dose descriptor (NOAEC): 50 mg/m^3
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of general population exposure: 7 days/week, 24 hours/day
Corrected inhalatory NOAEC for general population
= 50 mg/m^3 * (6/24)
= 12.5 mg/m³
Step 3: Use of assessment factors: 100
Interspecies AF, allometric scaling (rat to human): 1
Interspecies AF, remaining differences: 2.5
Intraspecies AF (general population): 10
Exposure duration AF: 4
Remaining uncertainties AF: 1
In conclusion, long term systemic inhalation DNEL, general population = 0.125 mg/m^3
Short term systemic inhalation DNEL, General population
The test material is not classified and labelled for acute systemic toxicity (inhalation), according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required.
Long term local inhalation DNEL, General population
The DNEL long term, local (inhalation) is derived from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC (local) is 0.5 mg/m^3.
Step 2: Modification of the starting point:
No modification for absorption is used as the same exposure route is considered. Following corrections were performed:
Relevant dose descriptor (NOAEC): 0.5 mg/m^3
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of general population exposure: 7 days/week, 24 hours/day
Corrected inhalatory NOAEC for general population
= 0.5 mg/m^3 * (6/24)
= 0.125 mg/m³
Step 3: Use of assessment factors: 25
Interspecies AF, allometric scaling (rat to human): 1
Interspecies AF, remaining differences: 2.5
Intraspecies AF (general population): 10
Exposure duration AF: 1 (No time extrapolation is conducted for local DNEL derivation.)
Remaining uncertainties AF: 1
In conclusion, long term local inhalation DNEL, general population = 0.005 mg/m^3
Short term local inhalation DNEL, General population
Short term local inhalation effects are covered by the long term local risk assessment and no quantitative acute local inhalation assessment is required (in accordance with "Guidance on information requirements and chemical safety assessment", Part E).
General population – Hazard via dermal route
Long term systemic dermal DNEL, General population
The DNEL long term, systemic (dermal) is derived by route-to route extrapolation from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC is 50 mg/m^3.
Step 2: Modification of the starting point:
Due to the physic-chemical properties the dermal uptake is considered to be 50 % of the inhalation uptake in the worst case.
Factor for dermal NOAEL= 100 % inhalation / 50 % dermal= 2
Standard respiratory volume of the rat (sRVrat) for 24 hours: 1.15 m³/kg bw/d
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of general population exposure: 7 days/week, 24 hours/day
inhalation NOAEC 50 mg/m^3 * 2 * 1.15 m³/kg bw/d * (6/24)= 28.75 mg/kg bw/day dermal NOAEL
Step 3: Use of assessment factors: 400
Interspecies AF, allometric scaling (rat to human): 4
Interspecies AF, remaining differences: 2.5
Intraspecies AF (general population): 10
Exposure duration AF: 4
Remaining uncertainties AF: 1
In conclusion, long term systemic dermal DNEL, general population = 0.071875 mg/kg bw/day
Short term systemic dermal DNEL, General population
The test material is classified for acute dermal toxicity cat. 4, according to Regulation (EC) No 1272/2008 (CLP). The acute systemic DNEL (dermal) is extrapolated from the long term DNEL with multiplication by factor of 3 (in accordance with "Guidance on information requirements and chemical safety assessment", chapter R8). The long term systemic DNEL (dermal) is derived from the repeated dose inhalation toxicity study.
For Steps 1-3 please refer to “Long term systemic dermal DNEL, General population”
Step 4: extrapolation from the long term DNEL
A factor of 3 is used: long term DNEL*3= short term DNEL
0.071875*3=0.215625 mg/kg bw/day
In conclusion, short term systemic dermal DNEL, general population = 0.215625 mg/kg bw/day
Long term local dermal DNEL, General population
The test material is not classified and labelled for skin sensitization or skin irritation, according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required.
Short term local dermal DNEL, General population
The test material is not classified and labelled for skin sensitization or skin irritation, according to Regulation (EC) No 1272/2008 (CLP). Thus, no DNEL is required.
General population – Hazard via oral route
Long term systemic oral DNEL, General population
The DNEL long term, systemic (oral) is derived by route-to route extrapolation from the repeated dose inhalation toxicity study.
Step 1: Selection of the relevant dose descriptor (starting point):
The repeated dose toxicity study is selected for DNEL derivation as it is the relevant repeated dose study performed in accordance to OECD guideline and GLP. In this study, the inhalation NOAEC is 50 mg/m^3.
Step 2: Modification of the starting point:
No default factor for adsorption is applied as a higher oral adsorption compared to inhalation adsorption is considered not justified (in accordance with "Guidance on information requirements and chemical safety assessment", chapter R8).
Standard respiratory volume of the rat (sRVrat) for 24 hours: 1.15 m³/kg bw/d
Frequency of exposure in study: 7 days/week, 6 hours/day
Frequency of general population exposure: 7 days/week, 24 hours/day
inhalation NOAEC 50 mg/m^3 * 1.15 m³/kg bw/d * (6/24)= 14.375 mg/kg bw/day dermal NOAEL
Step 3: Use of assessment factors: 400
Interspecies AF, allometric scaling (rat to human): 4
Interspecies AF, remaining differences: 2.5
Intraspecies AF (general population): 10
Exposure duration AF: 4
Remaining uncertainties AF: 1
In conclusion, long term systemic oral DNEL, general population = 0.0359375 mg/kg bw/day
Short term systemic oral DNEL, General population
The test material is classified for acute oral toxicity cat. 4, according to Regulation (EC) No 1272/2008 (CLP). The acute systemic DNEL (oral) is extrapolated from the long term DNEL with multiplication by factor of 3 (in accordance with "Guidance on information requirements and chemical safety assessment", chapter R8). The long term systemic DNEL (oral) is derived from the repeated dose inhalation toxicity study.
For Steps 1-3 please refer to “Long term systemic oral DNEL, General population”
Step 4: extrapolation from the long term DNEL
A factor of 3 is used: long term DNEL*3= short term DNEL
0.0359375*3=0.1078125 mg/kg bw/day
In conclusion, short term systemic oral DNEL, general population = 0.1078125 mg/kg bw/day
General population – Hazard for the eyes
For exposure to the eyes a low hazard was identified, as the test substance is classified for eye irritation Cat.2 according to Regulation (EC) No 1272/2008 (CLP). A qualitative risk assessment is conducted (in accordance with "Guidance on information requirements and chemical safety assessment", Part E).
References
(not included as endpoint study record)
- ECHA (2012). Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Version 2.1. November 2012.
- ECHA (2014). Guidance on information requirements and chemical safety assessment.Chapter R.7.12: Endpoint specific guidance: Guidance on Toxicokinetics. November 2014.
- ECHA (2012) Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report, November 2012.
- ECHA (2016). Guidance on information requirements and chemical safety assessment.Part E: Risk Characterisation, Version 3.0, May 2016.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.